Conor Kilroy

CIK: 0001808510

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AURA

Aura Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

AURA
Aura Biosciences, Inc.
Jul 1, 2026
Award(A)
Direct
14.9K shares-
AURA
Aura Biosciences, Inc.
Apr 16, 2026
Sale(S)
Direct
11.7K shares at avg. $7.02$82K
AURA
Aura Biosciences, Inc.
Mar 2, 2026
Award(A)
Direct
62.3K shares-
AURA
Aura Biosciences, Inc.
Feb 17, 2026
Sale(S)
Direct
12.1K shares at avg. $5.05$61K
AURA
Aura Biosciences, Inc.
Apr 16, 2025
Sale(S)
Direct
7.2K shares at avg. $5.49$39K
AURA
Aura Biosciences, Inc.
Feb 3, 2025
Award(A)
Direct
90.5K shares-

		Type	Shares	Price		Ownership
Jul 1, 2026	AURA Aura Biosciences, Inc.	Award(A)	14,858	-	$0	Direct
Apr 16, 2026	AURA Aura Biosciences, Inc.	Sale(S)	11,738	$7.02	$82,401	Direct
Mar 2, 2026	AURA Aura Biosciences, Inc.	Award(A)	62,339	-	$0	Direct
Feb 17, 2026	AURA Aura Biosciences, Inc.	Sale(S)	12,079	$5.05	$60,999	Direct
Apr 16, 2025	AURA Aura Biosciences, Inc.	Sale(S)	7,162	$5.49	$39,319	Direct
Feb 3, 2025	AURA Aura Biosciences, Inc.	Award(A)	90,475	-	-	Direct

1-6 of 6 transactions

About Kilroy Conor

Kilroy Conor (SEC CIK 0001808510) files insider reports with the SEC as Officer of Aura Biosciences, Inc. (AURA).

Signal8 holds 6 ownership filings by Kilroy Conor, all Form 4s, filed between Feb 4, 2025 and Jul 1, 2026. Those filings report 6 transactions, from Feb 3, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kilroy Conor's filings is in BOSTON, MA.

Recent filings by Kilroy Conor

Jul 1, 2026: Grant or award of AURA shares (Form 4, code A).
Apr 16, 2026: Open-market sale of AURA shares (Form 4, code S).
Mar 2, 2026: Grant or award of AURA shares (Form 4, code A).
Feb 17, 2026: Open-market sale of AURA shares (Form 4, code S).
Apr 16, 2025: Open-market sale of AURA shares (Form 4, code S).

Other insiders filing for Aura Biosciences, Inc. (AURA)

Person Julie, Chief People Officer
Kratz Erica, Chief Reg. & Quality Officer
Hopkins Janet Jill, Chief Medical Officer
Elazzouzi Amy, SVP, Finance & PAO
Abu-Absi Susan, Chief Operating Officer
Bender Jeremy, Director

How to read Form 4 transaction codes